transmiss
hospit
set
season
influenza
virus
novel
agent
middl
east
respiratori
syndrom
coronaviru
merscov
welldescrib
poorli
understood
character
potenti
infecti
bioaerosol
healthcar
set
remain
import
yet
illdefin
factor
transmiss
respiratori
virus
empir
data
describ
distribut
bioaerosol
enabl
discern
potenti
exposur
risk
respiratori
virus
sought
determin
distribut
influenza
viru
rna
emit
air
particip
laboratoryconfirm
influenza
whether
emiss
potenti
reach
healthcar
worker
breath
zone
twostag
cyclon
bioaerosol
sampler
center
diseas
control
prevent
nation
institut
occup
safeti
health
place
near
field
far
field
infect
patient
particip
well
corridor
immedi
outsid
room
addit
healthcar
worker
particip
provid
care
infect
particip
recruit
wear
polytetrafluoroethylen
ptfe
filter
cassett
breath
zone
viral
rna
detect
air
emit
particip
infect
influenza
viru
distribut
near
far
field
test
particl
size
mm
mm
mm
viral
rna
recov
droplet
nuclei
beyond
naturallyinfect
particip
healthcar
set
breath
zone
one
healthcar
worker
correl
patient
particip
nasal
viral
load
recoveri
viral
rna
air
identifi
signific
associ
rna
detect
air
patient
demograph
clinic
present
substanti
studi
requir
identifi
patient
determin
viru
emiss
air
delin
implic
evidencebas
polici
prevent
control
keyword
bioaerosol
exposur
healthcar
worker
respiratori
viru
contact
samira
mubareka
samiramubareka
sunnybrookca
bayview
ave
suit
toronto
canada
color
version
one
figur
articl
found
onlin
wwwtandfonlinecomuoeh
patient
acut
infecti
respiratori
ill
may
emit
bioaerosol
contain
pathogen
capabl
infect
suscept
host
includ
patient
healthcar
worker
hcw
lack
insight
determin
host
bioaerosol
emiss
spread
establish
emerg
pathogen
import
identifi
mean
control
potenti
infecti
bioaerosol
underscor
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
outbreak
burden
ill
death
larg
born
healthcar
worker
part
chao
character
sarscov
epidem
attribut
lack
knowledg
regard
rout
transmiss
sarscov
appropri
use
person
protect
equip
ppe
unfortun
similar
scenario
unfold
recent
saudi
arabia
south
korea
middl
east
respiratori
syndrom
coronaviru
merscov
spread
within
healthcar
institut
also
first
case
confirm
merscov
north
america
healthcar
worker
attack
rate
hcw
work
unit
care
mer
patient
one
studi
radiolog
technologist
respiratori
therapist
nurs
highest
risk
individu
report
within
infect
patient
extens
environment
contamin
merscov
outbreak
south
korea
demonstr
may
part
explain
superspread
event
merscov
sarscov
similarli
annual
spread
season
influenza
viru
within
healthcar
institut
pose
ongo
risk
patient
famili
healthcar
worker
approxim
influenza
case
healthcareassoci
acquir
acut
care
set
influenza
viru
rna
recov
breath
zone
particip
emerg
room
worker
nurs
nurs
assist
experienc
highest
frequenc
posit
viral
rna
detect
person
breath
zone
ten
particip
nurs
involv
aerosolgener
procedur
influenza
viru
rna
also
recov
ambient
air
acut
care
unit
outpati
clinic
underscor
potenti
exposur
across
healthcar
system
convent
paradigm
classifi
respiratori
pathogen
transmiss
droplet
vs
airborn
clear
polici
procedur
purport
mode
transmiss
doubt
droplet
airborn
precaut
gener
employ
larg
respiratori
droplet
mm
diamet
involv
shortrang
droplet
spread
droplet
nuclei
mm
respons
shortor
longrang
airborn
transmiss
respir
particl
small
enough
inhal
alveoli
rel
contribut
rout
overal
transmiss
influenza
unknown
lead
debat
regard
import
mode
transmiss
appropri
mean
transmiss
prevent
paper
use
term
bioaerosol
denot
particl
size
presum
origin
respiratori
tract
primari
goal
determin
distribut
viral
rna
particl
size
distanc
inpati
set
establish
whether
influenza
viru
rna
could
recov
hcw
breath
zone
also
sought
identifi
host
determin
recoveri
viral
rna
air
particip
identifi
daili
review
respiratori
viru
test
log
decemb
combin
acut
care
teach
hospit
longterm
care
facil
part
routin
care
midturbin
mt
swab
copan
murrieta
ca
usa
collect
individu
fever
either
cough
andor
sore
throat
requir
admiss
hospit
b
resid
longterm
care
submit
analysi
use
xtag
rvp
fast
luminex
toronto
canada
multiplex
pcr
assay
respiratori
virus
includ
target
influenza
subtyp
b
virus
inclus
criteria
includ
laboratoryconfirm
influenza
pcr
assay
median
fluoresc
intens
mfi
hr
sinc
mt
swab
obtain
abil
consent
minimum
mfi
arbitrarili
set
optim
air
sampl
yield
given
limit
number
instrument
personnel
avail
clinic
data
pertain
past
medic
histori
histori
present
ill
manag
outcom
collect
chart
review
patient
interview
addit
nurs
hcw
particip
provid
direct
care
recruit
individu
laboratoryconfirm
influenza
patient
particip
approach
hcw
particip
exclud
report
current
upper
respiratori
tract
symptom
mt
swab
obtain
exclud
contamin
air
sampl
asymptomat
shed
studi
conduct
approv
sunnybrook
human
research
protect
program
research
ethic
board
inform
consent
obtain
patient
hcw
particip
patient
singlepati
room
droplet
precaut
routin
practic
use
glove
gown
eye
protect
procedur
surgic
mask
daili
clean
hightouch
surfac
place
per
institut
protocol
air
handl
isol
heat
ventil
cool
hvac
system
unit
locat
hepafilt
maintain
regular
filter
chang
provid
minimum
four
six
air
exchang
per
hour
variabl
proport
recycl
air
depend
unit
locat
neg
pressur
isol
hepafiltr
increas
air
exchang
routin
appli
area
air
sampl
proxim
patient
collect
use
niosh
twostag
cyclon
bioaerosol
sampler
nation
institut
occup
safeti
health
morgantown
wv
usa
instrument
consist
stage
collect
particl
mm
ml
conic
tube
stage
mm
ml
conic
tube
stage
particl
mm
recov
mm
pore
size
mm
polytetrafluoroethylen
ptfe
membran
filter
millipor
etobicok
canada
hous
threepiec
cassett
prior
use
twostag
cyclon
sampl
devic
connect
batterypow
pump
skc
inc
eightyfour
pa
usa
calibr
averag
flow
rate
lmin
use
bio
drycal
flow
calibr
skc
inc
eightyfour
pa
usa
instrument
posit
cart
distanc
particip
head
corridor
immedi
outsid
room
height
rang
floor
bedsid
level
collect
period
restrict
patient
visitor
hcw
activ
twostag
cyclon
sampler
place
cooler
transport
onsit
laboratori
process
immedi
describ
postsampl
pump
flow
rate
verifi
ensur
exceed
target
percent
rel
humid
rh
temperatur
record
sampler
locat
particip
corridor
begin
sampl
period
addit
neg
air
sampl
control
taken
near
end
influenza
season
marchjun
end
novemb
begin
three
inpati
unit
sampl
occur
influenza
season
total
six
air
sampl
collect
corridor
use
niosh
bioaerosol
sampler
n
ptfe
cassett
n
lmin
hr
one
air
sampl
collect
within
laboratori
use
ptfe
cassett
hcw
breath
zone
air
sampl
collect
use
mm
pore
size
mm
ptfe
cassett
skc
inc
eightyfour
pa
usa
clip
particip
collar
attach
calibr
portabl
batterypow
pump
gilair
sensidyn
st
petersburg
fl
usa
worn
back
hip
pack
sampl
perform
nomin
flow
rate
lmin
hr
hcw
shift
time
hcw
perform
usual
assign
duti
insid
outsid
particip
room
includ
provid
care
patient
end
sampl
period
hcw
complet
brief
questionnair
estim
time
spent
room
presenc
aerosolgener
procedur
care
patient
acut
respiratori
symptom
ptfe
cassett
place
cooler
end
sampl
period
process
onsit
research
personnel
even
follow
morn
describ
follow
section
viral
rna
elut
stage
stage
filter
twostag
cyclon
sampler
vortex
min
ml
ml
ml
viral
transport
medium
dmem
bsa
penicillinstreptomycin
respect
store
c
total
rna
ml
mt
swab
air
sampl
extract
use
magmax
viral
rna
isol
kit
thermofish
scientif
mississauga
canada
onestep
qrtpcr
carri
use
superscript
iii
platinum
one
step
qrtpcr
kit
thermofish
scientif
mississauga
canada
quantifi
influenza
influenza
b
viru
rna
abi
fast
absolut
quantit
thermofish
scientif
mississauga
canada
rna
transcript
util
develop
standard
curv
reaction
volum
contain
ml
extract
rna
templat
mm
primer
mm
probe
follow
cycl
condit
use
revers
transcript
c
min
initi
denatur
c
min
follow
amplif
cycl
c
sec
c
min
final
extens
c
min
target
influenza
b
virus
matrix
gene
nucleoprotein
gene
respect
influenza
viru
primer
probe
sequenc
forward
revers
probe
influenza
b
viru
primer
probe
sequenc
forward
revers
probe
limit
detect
assay
copiesml
copiesml
influenza
b
virus
respect
limit
quantit
copiesml
copiesml
effici
pcr
posit
influenza
viru
base
threshold
cycl
c
quantit
provid
c
presenc
robust
amplif
curv
viral
load
mt
swab
air
sampl
record
log
copiesml
copiesl
air
sampl
respect
rnase
p
use
refer
gene
former
absolut
quantit
use
latter
absenc
refer
gene
air
rnase
p
qrtpcr
perform
multiplex
cycl
condit
describ
influenza
b
virus
rnase
p
primer
probe
sequenc
forward
revers
probe
air
volum
calcul
product
sampl
time
calibr
flow
rate
depend
variabl
identifi
mt
swab
viral
load
log
copiesml
detect
viral
rna
one
particip
air
sampl
posit
vs
neg
air
sampl
wilcoxonmannwhitney
kruskal
walli
test
spearman
correl
use
assess
presenc
statist
signific
correl
distribut
independ
variabl
mt
swab
viral
load
wilcoxonmannwhitney
fisher
exact
test
use
air
sampl
statist
analysi
perform
use
sa
univers
edit
sa
institut
cari
nc
usa
sixteen
patient
seven
hcw
recruit
januari
april
case
influenza
communityacquir
median
length
stay
day
mean
number
day
rang
day
two
patient
admit
intens
care
one
requir
mechan
ventil
death
attribut
influenza
tabl
four
nine
patient
particip
infect
influenza
influenza
virus
respect
three
particip
infect
influenza
b
viru
insuffici
mt
sampl
quantif
one
patient
influenza
viru
one
patient
influenza
b
viru
mean
median
log
copiesml
mt
swab
viral
load
patient
avail
sampl
sd
iqr
respect
patient
posit
influenza
viru
swab
mean
median
log
copiesml
mt
swab
viral
load
sd
iqr
patient
swab
posit
influenza
viru
mean
median
mt
swab
viral
load
sd
iqr
log
copiesml
mean
median
mt
swab
viral
load
patient
influenza
ident
sd
iqr
log
copiesml
final
mean
median
mt
swab
viral
load
patient
posit
influenza
b
viru
swab
sd
iqr
log
copiesml
statist
signific
differ
mt
viral
load
age
sex
number
symptom
pharyng
need
oxygen
vaccin
statu
smoke
statu
chest
xray
chang
howev
statist
signific
associ
higher
viral
load
fever
pvalu
four
particip
sampl
emerg
depart
inpati
unit
includ
one
critic
care
influenza
viru
rna
recov
one
room
air
sampl
particip
influenza
least
one
three
size
rang
mm
mm
mm
five
case
two
case
corridor
three
case
figur
two
insuffici
quantiti
repeat
pcr
rangesdist
one
includ
small
quantiti
rna
detect
corridor
statist
analysi
includ
neg
air
sampl
group
although
includ
figur
detect
viral
rna
recov
air
emit
three
particip
influenza
b
viru
infect
averag
percent
rel
humid
rh
sd
rang
averag
temperatur
c
sd
rang
c
correl
patient
demograph
clinic
characterist
air
sampl
result
tabl
also
associ
median
rel
humid
bioaerosol
posit
seven
hcw
particip
recruit
three
estim
spent
min
less
patientparticip
room
three
estim
min
spent
one
estim
hour
spent
room
patient
particip
wear
portabl
sampler
hcw
particip
present
aerosolgener
procedur
two
care
patient
acut
respiratori
symptom
influenza
viral
rna
recov
breath
zone
one
seven
hcw
provid
care
particip
influenza
viru
infect
particl
size
unknown
sinc
ptfe
filter
collect
particl
mm
otherwis
sizefraction
individu
care
anoth
patient
symptom
estim
spend
less
min
patient
particip
room
viral
rna
recov
air
emit
patient
particip
area
sampl
midturbin
swab
particip
hcw
neg
respiratori
virus
xtag
rvp
fast
viral
rna
undetect
neg
control
air
sampl
issu
pump
flow
rate
note
postsampl
recalibr
determin
particip
present
acut
care
facil
laboratoryconfirm
influenza
emit
viral
rna
air
viral
rna
detect
particl
recov
size
rang
mm
mm
mm
major
emit
near
field
particip
rna
detect
aerosol
sampl
collect
particip
influenza
b
viru
infect
howev
sampl
size
small
posit
rate
emit
aerosol
studi
similar
found
other
although
less
previou
studi
killingley
et
al
also
recov
viral
rna
size
rang
use
niosh
cyclon
sampler
although
other
recov
rna
submicron
rang
use
instrument
studi
signific
associ
fever
viral
load
midturbin
swab
particip
attribut
includ
nasal
viral
load
detect
influenza
viru
rna
emit
air
viral
rna
detect
one
seven
hcw
breath
zone
period
provid
routin
care
particip
influenza
understand
respiratori
pathogen
transmiss
via
bioaerosol
continu
press
issu
endem
virus
season
influenza
virus
well
novel
agent
avian
influenza
merscov
spread
hospit
set
season
pandem
influenza
virus
merscov
may
result
substanti
amplif
transmiss
ill
death
among
patient
well
healthcar
worker
sever
studi
involv
human
subject
reveal
influenza
viru
rna
detect
smaller
mm
aerosol
particl
aerosol
present
healthcar
set
infect
subject
gener
particl
per
cough
infect
compar
convalesc
substanti
proport
particl
respir
mm
anoth
studi
vs
naturallyinfect
volunt
laboratoryconfirm
influenza
shed
viru
fine
mm
vs
coars
mm
exhal
particl
studi
infect
volunt
emit
aerosol
contain
viabl
influenza
viru
cough
quiet
breath
respect
viabl
viru
isol
smallest
particl
fraction
mm
largest
bedsid
air
sampl
studi
date
n
bischoff
et
al
determin
nasal
viral
load
correl
emiss
viral
rna
air
p
particularli
expuls
event
cough
sneez
emitt
emerg
depart
report
greater
sever
ill
p
interf
activ
daili
live
p
studi
also
demonstr
presenc
rnabear
droplet
nuclei
abund
near
field
compar
far
field
vs
anoth
studi
examin
emiss
otherwis
healthi
colleg
student
determin
coars
fine
particl
shed
includ
frequenc
cough
bodi
mass
index
infecti
viru
recov
sampl
exhal
min
gesundheitii
human
sourc
bioaerosol
sampler
focu
countssampl
recov
determin
whether
median
rel
humid
correl
air
sampl
result
found
statist
signific
although
sampl
size
limit
imped
abil
reach
robust
conclus
similar
studi
conduct
twobe
isol
hospit
room
rel
humid
continu
monitor
durat
sampl
period
correl
rh
total
concentr
influenza
viru
rna
air
found
although
outlier
remov
posit
associ
observ
addit
small
sampl
size
current
studi
sever
limit
substanti
variabl
patient
emiss
viral
rna
compound
limit
sampl
size
imped
possibl
identifi
signific
associ
individu
host
differ
sampl
differ
point
patient
clinic
cours
depend
time
present
like
contribut
variabl
despit
sampl
patient
within
strict
time
frame
rel
present
hospit
time
onset
symptom
vari
includ
analysi
recov
viral
rna
breath
zone
one
seven
particip
hcw
record
specif
activ
undertaken
sampl
period
unknown
exactli
much
time
hcw
particip
spent
close
proxim
patient
particip
similarli
patient
particip
activ
monitor
record
expuls
event
cough
restrict
visitor
place
sampl
period
thu
possibl
household
member
visitor
may
contribut
viral
rna
air
exclud
record
presenc
patient
influenza
unit
ill
staff
may
contribut
detect
viral
rna
particularli
corridor
exact
air
exchangeshour
ventil
direct
flow
rate
determin
may
affect
particl
distribut
room
corridor
also
although
patient
particip
droplet
precaut
consist
door
closur
note
although
import
limit
data
collect
uncontrol
condit
reflect
real
world
patient
hcw
exposur
actual
occur
major
studi
natur
detect
viral
rna
definit
indic
potenti
risk
infect
exposur
experiment
studi
suggest
viabl
viru
concentr
severalfold
lower
detect
rna
copi
concentr
clinic
set
differ
may
due
technic
mechan
factor
relat
sampl
disrupt
viral
envelop
may
attribut
biolog
factor
includ
shed
defect
interf
viral
particl
di
particl
role
di
particl
influenza
viru
transmiss
remain
unclear
though
evid
role
transmiss
virus
stand
demonstr
infecti
viru
aerosol
sampl
remain
convinc
evid
transmiss
potenti
even
viral
rna
becom
reliabl
indic
exposur
translat
result
manag
reduc
risk
requir
significantli
research
sinc
littl
known
transmiss
potenti
given
quantiti
viru
shed
air
final
studi
repres
singl
center
singl
influenza
season
although
sampl
window
includ
influenza
peak
bulk
sampl
done
februari
whilst
virus
predomin
earli
particular
season
virus
emerg
later
predomin
entir
season
reflect
tabl
show
major
recruit
particip
infect
viru
delay
identifi
potenti
emitt
present
acut
care
noncompli
infect
prevent
control
precaut
may
pose
signific
risk
hcw
provid
direct
patient
care
one
risk
analysi
occupationallyacquir
case
influenza
estim
occur
annual
unit
state
inconsist
applic
infect
prevent
control
measur
hcw
patient
studi
opportun
improv
among
group
well
administr
perspect
recoveri
viral
rna
droplet
nuclei
beyond
naturallyinfect
particip
healthcar
set
invit
concert
effort
address
issu
viru
viabil
potenti
risk
exposur
b
determin
emiss
former
pose
methodolog
technic
challeng
wherea
latter
requir
collabor
multidisciplinari
multicent
undertak
multicent
multiseason
studi
requir
determin
clinic
environment
viral
factor
associ
emiss
dispers
influenza
viru
issu
address
order
gener
empir
data
requir
enhanc
evidencebas
infect
prevent
control
occup
health
polici
